Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

October 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza split vaccine of 15 μg HA

60 subjects were assigned (20 infants, 20 children and 20 adults) to receive influenza vaccine (split virion), inactivated, 0.5ml, one dose regime

BIOLOGICAL

Influenza split vaccine of 15 μg HA

558 subjects were assigned to receive influenza split vaccine, 0.5ml, one dose regime

BIOLOGICAL

Influenza split vaccine

280 subjects were assigned to receive influenza split vaccine, 0.5ml, one dose regime

Trial Locations (1)

210000

Jiangsu Provincial Center for Disease Prevention and Control, Nanjing

All Listed Sponsors
lead

Hualan Biological Engineering, Inc.

INDUSTRY